Evidence map›Paper›PMID 42797444›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Triple-Frequency Electromagnetic Stimulation Combined with Fingolimod Reduces Breast Cancer Cell Proliferation and Metastasis-Associated Extracellular Vesicle Protein Levels.

Greg Haroutunian, Lawrence Daniels, Ashot Tsaghikian, Caifeng Zhao, Phaedon Zavras, Svetlana Marukian, Haiyan Zheng, Arevik Mosoian

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Greg HaroutunianDepartment of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Lawrence DanielsNew Neurons LLC., Cedar Knolls, NJ 07927, USA.
Ashot TsaghikianData Processing and Field Engineering Corp., Glendale, CA 91214, USA.
Caifeng ZhaoCenter for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, NJ 08854, USA.
Phaedon ZavrasDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Svetlana MarukianFL106 Inc., c/o Flagship Pioneering, Cambridge, MA 02142, USA.
Haiyan ZhengCenter for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, NJ 08854, USA.
Arevik MosoianEnergyBioCode LLC., Cedar Knolls, NJ 07927, USA.ORCID 0000-0003-0700-5210

Funding

A Bruker timsTOF HT mass spectrometer and nanoflow LC system to upgrade the proteomics facility at Rutgers-New Brunswick and Robert Wood Johnson Medical SchoolS10OD036226 · OD · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI ZHENG, HAIYAN · 2024 to 2024
$1.1M
New Jersey Commission on Science, Innovation and Technology PROD-00319650NIH HHS S10 OD036226
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerelectromagnetic stimulationextracellular vesiclesFingolimod (FTY720)triple frequencyTRPM7

Identifiers

PMID42797444
PMCPMC13610236

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.